Abstract |
Chondrosarcoma is a type of an endochondral bone malignancy that is primarily treated surgically with radiation therapy used in the adjuvant setting or in cases of unresectable disease. Proton therapy has potential advantages compared with traditional photon therapy for the treatment of tumors in close proximity to critical structures due to the theoretic lower exit dose. Studies have shown improved survival in patients with skull base chondrosarcoma who undergo proton therapy. However, there is a lack of randomized data. Further studies are needed to define the role of proton therapy in the treatment of skull base chondrosarcoma.
|
Authors | Dennis M Tang, Raffaello M Cutri, Arthur W Wu, Chirag Patil, Zachary S Zumsteg |
Journal | Journal of neurological surgery reports
(J Neurol Surg Rep)
Vol. 84
Issue 4
Pg. e144-e145
(Oct 2023)
ISSN: 2193-6358 [Print] Germany |
PMID | 38026146
(Publication Type: Journal Article)
|
Copyright | The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ). |